Sequential nano-catalytic
therapy has emerged as a novel therapeutic modality for
cancer treatment as it utilizes the unique tumor microenvironment for selective
tumor treatment. This study reports a magnetic nanoparticle to achieve Fenton-like reaction and dual-imaging guidance/monitoring. Natural
glucose oxidase (GOx) and superparamagnetic Fe3O4 nanoparticles have been integrated into
poly(lactic-co-glycolic acid) (PLGA) to fabricate a sequential nanocatalyst (designated as GOx@PLGA-Fe3O4). This nanocatalyst can functionally deplete
glucose in
tumor tissues, producing a considerable amount of highly cytotoxic
hydroxyl radicals via the sequential Fenton-like reaction, and meanwhile maximizing the potential imaging capability as a
contrast agent for magnetic resonance imaging and photoacoustic imaging. By
ribonucleic acid sequencing (
RNA-seq) technology, GOx@PLGA-Fe3O4 nanoparticles are demonstrated to induce
tumor cell death by inhibiting multiple gene regulation pathways involving
tumor growth and recurrence. Therefore, this finding provides a novel strategy to achieve promising therapeutic efficacy by the rational design of multifunctional nanoparticles with various features, including magnetic targeting, sequential nano-catalytic
therapy, and dual-imaging guidance/monitoring.